Finland· FI-REL-REL63537
Ontozry
A cenobamate product containing cenobamate, registered in Finland by Orifarm Oy. The same ATC class is registered in 15 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Cenobamate is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AX25 (cenobamate), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Cenobamate · ATC N03AX25
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cenobamate costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $4.11 in France to $21.72 in Switzerland — a ×5.3 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cenobamate · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$21.72
- IT Italy$19.89
- CZ Czechia$4.12
- FR France$4.11
The record
At a glance
Fimea (Finland)- Active substance
- Cenobamate
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- N03AX25
- ATC class
- Cenobamate
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa17530828EUR 161.99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for cenobamate.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cenobamate · interactions on record
273 records
- 29 severe
- 237 moderate
- 7 minor
Most severe, free to view
- DeflazacortH02AB13severe
- BosutinibL01EA04severe
- EncorafenibL01EC03severe
- BrigatinibL01ED04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cenobamate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaONTOZRYAngelini Pharma S.p.A, Rome
- NorwayOntozryAngelini Pharma S.p.A.
- SwitzerlandOntozry 200 mg, FilmtablettenAngelini Pharma S.p.A., Rom, Zweigniederlassung Zug
- United StatesXcopriSK Life Science, Inc.
- NetherlandsOntozry 200mg, filmomhulde tabletAngelini Pharma S.p.A
- PolandOntozryAngelini Pharma S.p.A.
- SwedenOntozry 200 mg Filmdragerad tablettAngelini Pharma S.p.A.
- IrelandOntozry 200 mg film-coated tabletsAngelini Pharma Italia S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ontozry
- Liechtenstein · Ontozry
- Norway · Ontozry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/efb6bcf1-f75b-4ff4-9b71-907e79772585 GET /v1/drugs/efb6bcf1-f75b-4ff4-9b71-907e79772585?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.2",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "200 mg",
"atc_label": "senobamaatti",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/21/1530/012",
"fimea_rel_id": "REL63537",
"authorised_at": "2024-12-03"
}See everything about cenobamate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.